Second TAMC event to take place in October
The Aesthetic Medicine Congress (TAMC), in association with the British College of Aesthetic Medicine, will take place in Dubrovnik on October 12 and 13.
The Aesthetic Medicine Congress (TAMC), in association with the British College of Aesthetic Medicine, will take place in Dubrovnik on October 12 and 13.
Global pharmaceutical company Allergan has manufactured the 100 millionth vial of botulinum toxin type A Botox, which the company has said is a ‘significant milestone in the history of the brand’.
Global pharmaceutical company Allergan is launching a website to support healthcare professionals working within medical aesthetics called Allergan Spark.
The Food and Drug Administration (FDA) has approved Jeuveau, a botulinum toxin type A, for the temporary improvement in the appearance of moderate to severe glabellar lines.
High street retailer Superdrug, which started offering a botulinum toxin and dermal filler service last year, has said that it will introduce tougher mental health checks for patients as a result of concerns voiced by the NHS.
IQ Resources, a sister company to IQ Verify, a UKAS accredited certification body has launched a new eLearning package titled the Botulinum Toxin and Dermal Filler Level 7 eLearning.
We bring you the most up-to-date information for the Aesthetics community across a variety of media, including; news, webinars, podcasts, the Journal, reports, interviews and more!
aesthetics Journal
The Aesthetics Journal is the leading monthly publication for the medical aesthetics specialty. It is peer reviewed and spans an incredible volume of topics. Become a member today to receive the monthly print and digital Journal.
0203 096 1228
2nd Floor, Regal House, 70 London Road
Twickenham TW1 3QS, United Kingdom
© 2023 Easyfairs UK Ltd | Registered in England No. 05067979